Mergers and Acquisitions
Brachytherapy seed developer announces merger
Published in Health and Medicine Week, July 26th, 2004
The new board will include Vincent E. Low, a New York-based executive who has been active in biotechnology, real estate, and hospitality companies and has been involved in five public offerings to date.
The merger will combine IsoRay Inc.; IsoRay Management, LLC; and IsoRay Products, LLC into one corporate entity as the company readies for the introduction of its new U.S. Food and Drug Administration (FDA)-approved Cesium-131 brachytherapy seed, stated IsoRay's chief executive officer Roger...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Acoustic Neuroma
Translabyrinthine microsurgery preserves facial nerve function - Acute Coronary Syndromes
Two major studies show enoxaparin an effective alternative to heparin - Alzheimer Disease
5-year partnership aims to raise public awareness of Alzheimer disease - Alzheimer Disease
Possible "seed" for Alzheimer amyloid identified - Diet & Nutrition
Healthy eating and living can indeed reduce women's risk of getting cancer - Wound Healing
Chronic wounds: Hypothesis on their pathogenesis and implications for therapy - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
